Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE.
Azathioprine
/ therapeutic use
Encephalitis, Viral
/ immunology
Enterovirus Infections
/ immunology
Female
Humans
Immunocompromised Host
Immunosuppressive Agents
/ therapeutic use
Lupus Erythematosus, Systemic
/ drug therapy
Meningitis, Viral
/ immunology
Meningoencephalitis
/ immunology
Prednisolone
/ therapeutic use
Rituximab
/ therapeutic use
Young Adult
SLE
encephalitis
infectious diseases
neurovirology
Journal
Practical neurology
ISSN: 1474-7766
Titre abrégé: Pract Neurol
Pays: England
ID NLM: 101130961
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
accepted:
25
05
2019
pubmed:
7
6
2019
medline:
28
4
2020
entrez:
8
6
2019
Statut:
ppublish
Résumé
A young woman with systemic lupus erythematosus (SLE) developed recurrent enterovirus meningoencephalitis while taking prednisolone, azathioprine and rituximab. After reducing the immunosuppression, she developed a central nervous system (CNS) flare of SLE, with enterovirus still present in the cerebrospinal fluid (CSF). There are no evidence-based specific treatments for enterovirus encephalitis, but she responded well to intravenous immunoglobulin alongside pulsed methylprednisolone and rituximab. This case highlights the difficulties in managing people with co-existing infective and autoimmune conditions, especially if each affects the CNS. A viral infection and SLE flare can resemble one another clinically, although here the radiological differentiation of CNS lupus versus enterovirus encephalitis helped to guide the diagnosis.
Identifiants
pubmed: 31171649
pii: practneurol-2019-002229
doi: 10.1136/practneurol-2019-002229
doi:
Substances chimiques
Immunosuppressive Agents
0
Rituximab
4F4X42SYQ6
Prednisolone
9PHQ9Y1OLM
Azathioprine
MRK240IY2L
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
508-510Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.